Is there a link between the use of etanercept and Henoch-Schönlein purpura? Commentary on: Henoch-Schönlein purpura in a patient with rheumatoid arthritis receiving etanercept (Eur J Dermatol 2010; 20: 521-2)

European Journal of Dermatology

Volumn 21, Issue 1, 2011, Pages 147-

  Park, Se Jin ^a   Kim, Ji Hong ^a   Shin, Jae Il ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTINUCLEAR ANTIBODY; CYTOKINE; DNA ANTIBODY; ETANERCEPT; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; RHEUMATOID FACTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; ANTIRHEUMATIC AGENT; TNFR FC FUSION PROTEIN; TNFR-FC FUSION PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR;

ANAPHYLACTOID PURPURA; ANTIGEN ANTIBODY COMPLEX; B LYMPHOCYTE; HUMAN; HUMORAL IMMUNITY; LETTER; MEMORY CELL; PATHOGENESIS; RHEUMATOID ARTHRITIS; T LYMPHOCYTE; BLOOD; CHEMICALLY INDUCED DISORDER; IMMUNOLOGY; NOTE;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; PURPURA, SCHOENLEIN-HENOCH; RECEPTORS, TUMOR NECROSIS FACTOR; RHEUMATOID FACTOR;

EID: 79957479741     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2010.1198     Document Type: Letter

References (6)

1. Asahina A, Ohshima N, Nakayama H, Shirai A, Juji T, Matsui T. Henoch-Schönlein purpura in a patient with rheumatoid arthritis receiving etanercept. Eur J Dermatol 2010; 20: 521-2.
2. Duffy TN, Genta M, Moll S, Martin PY, Gabay C. Henoch-Schönlein purpura following etanercept treatment of rheumatoid arthritis. Clin Exp Rheumatol 2006; 24: S106.
3. Wu TH, Wu SC, Huang TP, Yu CL, Tsai CY. Increased excretion of tumor necrosis factor alpha and interleukin 1 beta in urine from patients with IgA nephropathy and Schönlein-Henoch purpura. Nephron 1996; 74: 79-88.
4. Saulsbury FT. IgA rheumatoid factor in Henoch-Schönlein purpura. J Pediatr 1986; 108: 71-6.
5. Yazdani-Biuki B, Stadlmaier E, Mulabecirovic A, et al. Blockade of tumour necrosis factor {alpha} significantly alters the serum level of IgG-and IgA-rheumatoid factor in patients with rheumatoid arthritis. Ann Rheum Dis 2005; 64: 1224-6.
6. Cunnane G, Warnock M, Fye KH, Daikh DI. Accelerated nodlois and vasculitis following etanercep therapy for rheumatoid arthritis. Arthritis Rheum 2002; 47: 445-9.